In common, recurrent genetic modifications that lead to NF-kB activation have been described in inflamed lymphomas including cHL, PMBL and a subset of T cell-rich DLBCLs that contain PD-L1 SVs and downregulated HLA expression (44, 155, 156). The gene discussed is CD274; the disease is lymphoma.